51视频

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 51视频 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • 51视频

    51视频

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Oct 2 2026 9:10 AM

Full Issue

21 Drugs Are Cleared For Back-End Payments In Revised Pilot Of 340B Program

Come Jan. 1, 10 pharmaceutical companies will pay rebates to providers only after it's been established that qualifying drugs were dispensed to eligible patients. Drugmakers have expressed concern that there is waste and fraud in the program, an allegation that hospitals say is overblown.

The Trump administration has released a highly anticipated list of 10 drugmakers that it will allow to shift discounts on drugs from upfront savings to back-end rebates in a controversial federal program. Starting Jan. 1, major pharmaceutical companies including AbbVie, Merck and Pfizer will only have to pay savings to providers participating in the 340B drug discount program after they verify the transaction qualifies, according to the Health Resources and Services Administration, the HHS subagency that oversees 340B. (Parduhn, 10/1)

Small hospitals, health centers and clinics are caught in the crosshairs of an intensifying fight over the 340B Drug Pricing Program. In recent years, drugmakers and hospitals have gone head-to-head over 340B. Hospitals argue the program is a critical funding lifeline and stretches their resources, while drugmakers contend its explosive growth and alleged misuse by large health systems necessitate reform. The 340B program, begun in 1992, offers participating providers discounts of 25% to 50% on an array of medications in exchange for manufacturers鈥� enrollment in the Medicaid program. (Early, 10/1)

More health news from the Trump administration 鈥�

The U.S. Department of Health and Human Services (HHS) awarded nearly $250 million in grants Friday aimed at expanding access to mental health services and addiction treatment across the nation. The $247.9 million in funds were distributed through HHS鈥� Substance Abuse and Mental Health Services Administration (SAMHSA). The projects receiving the highest amount of grant money are Medication-Assisted Treatment 鈥� Prescription Drug and Opioid Addiction ($69.4 million); Project AWARE ($54.9 million) National Child Traumatic Stress Initiative 鈥� Category III Community Treatment and Service Centers ($41.8 million) and First Responders - Comprehensive Addiction and Recovery Act ($34.6 million). (Gleeson, 10/1)

A proposed redesign of the federal government鈥檚 annual health survey would result in significant undercounting of Americans with intellectual and developmental disabilities, according to advocates for the vulnerable population. (Broderick, 10/1)

Bill Pulte, President Trump鈥檚 director of the Federal Housing Finance Agency, moved this week to slash the inspector general鈥檚 office that scrutinizes his actions, prompting calls from congressional Democrats for his resignation. It was the second time that Trump administration officials have taken steps to limit scrutiny of the federal regulatory agency run by Mr. Pulte, who has become one of the administration's most contentious figures because he prides himself on carrying out investigations into Mr. Trump鈥檚 rivals. (Broadwater, 10/1)

The agency announced this week that it is removing chairs at this position in airports throughout the country, requiring staff members to stand for their shift. In a statement, TSA explained the reason as twofold: to ensure its employees meet its fitness standards and to create an amiable environment for travelers. In a Facebook post, the American Federation of Government Employees TSA Council 100, the union that represents the officers, expressed concern over the agency鈥檚 鈥渃onsequential decision.鈥� The ergonomic chairs, the union argued, provide safety and support for officers who stand and walk on hard surfaces for extended periods. (Sachs, 10/1)

Health Secretary Robert F. Kennedy Jr. plans to announce a new nationwide competition for schools aimed at expanding participation in the Presidential Fitness Test, which President Donald Trump revived last year. The challenge will offer $7 million in prizes to schools, districts and youth organizations that demonstrate effective ways to implement the test, the Health and Human Services Department told NBC News. Another $3 million in awards and vouchers will be available for fitness or sports equipment. (Bendix, 10/1)

51视频 Health News: 51视频 Health News鈥� 鈥榃hat The Health?鈥�: The MAHA Metamorphosis

The big 鈥淢ake America Healthy Again鈥� summit at a glitzy Washington, D.C., hotel this week highlighted a split in the movement between moms who want pesticides and artificial ingredients out of their kids鈥� food and wellness entrepreneurs who want to promote their products to government regulators. Meanwhile, as the new fiscal year begins, the Trump administration is refusing for the second year in a row to spend hundreds of millions of dollars Congress approved for the Department of Health and Human Services 鈥� and daring lawmakers or the courts to try to do something about it. (Rovner, 10/1)

On the immigration crisis 鈥�

The Supreme Court on Thursday said it would review the legality of the Trump administration鈥檚 novel policy of denying bond hearings to immigrants swept up in its immigration crackdown. The case is one of the first the high court has accepted since its summer recess ended, and it promises to be among the most consequential of the term that officially begins next week. (Mark and Nakamura, 10/1)

The family of Ren茅e Good, who was shot and killed by a federal immigration officer during the Trump administration鈥檚 enforcement surge in Minneapolis earlier this year, has sued the United States and officials for her death. The family filed two civil lawsuits Thursday seeking accountability for what they described as a wrongful use of force that resulted in Good鈥檚 death and a broader effort to undermine the rights of Minneapolis residents. (Foster-Frau, 10/1)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, October 2
  • Thursday, October 1
  • Wednesday, September 30
  • Tuesday, September 29
  • Monday, September 28
  • Friday, September 25
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • 51视频
  • Privacy Policy

漏 2026 51视频